Meditrax S 250mg/125mg Injection
Marketer
Medicant Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Meditrax S 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats various bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, consistent adherence to the prescribed dosage is crucial; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (e.g., rash, pruritus, edema, dyspnea) warrant urgent medical help. Prior to commencing treatment, disclose all current medications and pre-existing conditions, including pregnancy or lactation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, a nutritious diet, and sufficient hydration support recovery. Monitoring via laboratory and diagnostic tests may be employed to assess treatment response.
Uses of Meditrax S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Meditrax S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Meditrax S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Meditrax S 250mg/125mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Meditrax S 250mg/125mg Injection works:
Ceftriaxone/Sulbactam Injection (Meditrax S 250mg/125mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Meditrax S 250mg/125mg Injection can be taken with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Meditrax S 250mg/125mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to fetuses; however, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Meditrax S 250mg/125mg Injection necessitates prudence during lactation. Nursing mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Meditrax S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating vehicles should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Meditrax S 250mg/125mg Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Meditrax S 250mg/125mg Injection to individuals with severe hepatic impairment requires careful consideration. Dosage modification of Meditrax S 250mg/125mg Injection might be necessary; physician consultation is advised. Altering the Meditrax S 250mg/125mg Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Meditrax S 250mg/125mg Injection :
Omit a Meditrax S 250mg/125mg Injection dose? Seek medical advice immediately.
Facts to Know About Meditrax S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently